vaccine: who pays? Hepatitis B vaccine: who pays?Hepatitis B vaccine: who pays?doi:http://dx.doi.org/10.1136/bmj.316.7142.1457Hilary ButlerBMJ
HepB-CpG could be the preferred vaccine in HCW nonresponders. Clinical Trials Registration. Clinicaltrials.gov NCT04456504.doi:10.1093/cid/ciae320Russ Rachel KVandehei Haley MGolovkina Maria IMogallapalli HarshithaCaldera FreddyHayney Mary S
Recommendations of the Advisory Committee on Immunization Practices for use of a hepatitis B vaccine with a novel adjuvant. MMWR Morb Mortal Wkly Rep. 2018;67(15):455-458. doi:10.15585/mmwr.mm6715a5. Engerix-B [prescribing information]. Research Triangle Park, NC: GlaxoSmithKline; 2018. gsk...
摘要: Assesses the immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine. Research design; Reactogenicity; Immunogenicity; Factors affecting the immune response; Guidelines for immunization; Zeroprotection and zeroconversion rates....
HPV Vaccine-Related Research, Promotion and Coordination in the State of Georgia: A Systematic Review information from National Immunization Survey-Teen, Community Health Needs Assessments, Behavioral Risk Factor Surveillance and Georgia Adolescent Immunization ... D Cori,AR King,R Hannah,... - 《...
Sixty-seven percent were aware of the hepatitis B vaccine, yet only 22% had received the full series of three injections; only 37% had been tested for the virus. On a scale of 1 to 10 for willingness to be vaccinated (10 being most willing), 58% indicated a 10 (M = 8.5). Thirty...
Chacham, A. S., Diniz, S. G., Maia, M. B., Galati, A. F., & Mirim, L. A. (2007). Sexual and reproductive health needs of sex workers: Two feminist projects in Brazil. Reproductive Health Matters, 15(29), 108–118. doi:10.1016/S0968-8080(07)29292-4. Article PubMed Google...
Studies on the duration of protection and the prevalence of non-responders in Indonesian adolescents have been limited.Objectives To determine anti-HBs titers in 15-17-year old Indonesian adolescents given primary HB vaccine during infancy and the prevalence of non-responders after a HB vaccine ...
The WHO Vaccine Trial Registry was established following on recommendations of an advisory panel convened in 1994 [1]. The panel suggested a registry would be useful to improve internal management of WHO-supported vaccine studies; to predict technical resource needs of future studies; to identify ...
Despite the availability of an effective vaccine for nearly 2 decades, our findings suggest that few adolescent and young adult MSM in the United States are vaccinated against hepatitis B, Health care providers should intensify their efforts to identify and vaccinate young MSM who are susceptible to...